+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Terbinafine"

Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 226 Pages
  • Global
From
Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Asia Pacific
From
North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 71 Pages
  • North America
From
LAMEA Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Middle East, Africa
From
Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Europe
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • August 2024
  • 229 Pages
  • China
From
Vaginal Antifungals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Vaginal Antifungals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 250 Pages
  • Global
Terbinafine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Terbinafine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 83 Pages
  • Global
From
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 30 Pages
  • Global
From
Terbinafine Hydrochloride (CAS 78628-80-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Terbinafine Hydrochloride (CAS 78628-80-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • April 2025
  • 50 Pages
  • Global
From
Anti-infectious Disease Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Anti-infectious Disease Drugs Industry Forecasts - China Focus

  • Report
  • August 2024
  • 93 Pages
  • China
From
Drugs for Vulvovaginal Candidiasis Market: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

Drugs for Vulvovaginal Candidiasis Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • October 2024
  • 240 Pages
  • Global
From
Antifungal Drugs Market By Drug Class, By Infection Type, By Therapeutic Indications, By Dosage Forms: Global Opportunity Analysis and Industry Forecast, 2020-2030 - Product Thumbnail Image

Antifungal Drugs Market By Drug Class, By Infection Type, By Therapeutic Indications, By Dosage Forms: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • Report
  • April 2022
  • 210 Pages
  • Global
From
Loading Indicator

Terbinafine is an antifungal drug used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is commonly used to treat skin and nail infections, such as athlete's foot, jock itch, and ringworm. It is also used to treat fungal infections of the scalp, fingernails, and toenails. Terbinafine is a member of the allylamine class of antifungal drugs, which are used to treat a variety of fungal infections. Terbinafine is a widely used antifungal drug in the infectious diseases drugs market. It is used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is generally well tolerated and has a low risk of side effects. Some companies in the Terbinafine market include Novartis, Pfizer, Merck, and GlaxoSmithKline. Show Less Read more